Canada Markets open in 23 mins

Senseonics Holdings, Inc. (SENS)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
3.5600+0.0600 (+1.71%)
At close: 4:00PM EDT
3.5600 0.00 (0.00%)
Pre-Market: 09:06AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.5000
Open3.5000
Bid3.5500 x 2900
Ask3.5800 x 2200
Day's Range3.4400 - 3.6500
52 Week Range0.3500 - 5.5600
Volume7,215,257
Avg. Volume10,416,078
Market Cap1.524B
Beta (5Y Monthly)0.53
PE Ratio (TTM)N/A
EPS (TTM)-1.4250
Earnings DateMay 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.46
  • Business Wire

    Senseonics Announces Equity Grants To Employees Under Inducement Plan

    GERMANTOWN, Md., October 04, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).

  • Zacks

    Implied Volatility Surging for Senseonics (SENS) Stock Options

    Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

  • Business Wire

    Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio

    GERMANTOWN, Md., September 13, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, and Ascensia Diabetes Care, the makers of the CONTOUR® family of diabetes blood glucose monitoring devices and commercialization partner for Senseonics, have announced that the University Hospitals Accountable Care Organiz